CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
PRINCETON, N.J., Aug. 13, 2024 ( GLOBE NEWSWIRE ) -- CytoSorbents Corporation ( NASDAQ: CTSO ) , a pioneer in critical care and cardiac surgery blood purification technologies, today reported unaudited financial and operating results for the quarter ended June 30, 2024.
| Ticker |
Sentiment |
Impact |
|
AXGN
|
Somewhat Bullish
|
2 %
|
|
META
|
Neutral
|
1 %
|
|
CTSO
|
Neutral
|
8 %
|
|
FSNUF
|
Somewhat Bullish
|
1 %
|
|
FOREX:EUR
|
Neutral
|
17 %
|
|
FOREX:USD
|
Neutral
|
10 %
|
